YCBD — what changed in the latest 10-Q
A section-by-section comparison of YCBD's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-13 vs the prior 10-Q · 2026-05-14
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +15 | −15 | ~14 | 26 |
| Controls & procedures | No paragraph-level changes | 0 | 0 | 0 | 2 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | 0 | 0 | ~1 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Market risk (Item 3)
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-13
Management continues to pursue other M&A activity and incurred over $100,000 in legal and due diligence expenses on pursuing other transactions that would further diversify the Company's revenue and mitigate certain regulatory risks facing the hemp industry.
Numerous bills in the 119th Congress would repeal, delay, or modify Section 781 of Public Law 119-37 or establish a federal framework for hemp-derived cannabinoid products, including H.R. 6209, H.R. 7024/S. 3686, S. 3474, H.R. 7212, and S. 4315, none of which has advanced beyond committee. Most prom…
We remain focused on positioning the Company for a changing regulatory landscape. During the second and third quarters, we made progress on the following key initiatives:
Revenue Maximization: At the end of the third quarter, we added South Carolina distribution for Oasis and transitioned to a new distribution partner in Texas, which more than quadrupled the stores we have access to and we are seeing market growth in the fourth quarter of fiscal 2026. The launch of o…
Cost control and Right Sizing: Beginning in the fourth fiscal quarter of 2026, we implemented a plan targeting $100,000 to $150,000 in monthly cost savings, or approximately $1.2 to $1.8 million on an annualized basis. These are principally fixed-cost reductions and to date have included payroll red…
Text removed vs the prior filing · source: 10-Q · 2026-05-14
Multiple legislative measures have been introduced in the 119th Congress that would repeal, delay, or modify Section 781 of Public Law 119-37, or that would establish a federal regulatory framework for hemp-derived cannabinoid products. These include H.R. 6209 (repeal of Section 781); H.R. 7024 and …
On April 1, 2026, the Centers for Medicare & Medicaid Services (“CMS”) activated the Substance Access Beneficiary Engagement Incentive (“BEI”), under which approved participants in the ACO REACH Model and Enhancing Oncology Model may furnish eligible hemp-derived products to Medicare beneficiaries, …
On April 23, 2026, the Acting Attorney General issued a final order, effective April 28, 2026, rescheduling certain narrow categories of marijuana — FDA-approved drug products and state-licensed medical marijuana — from Schedule I to Schedule III under the Controlled Substances Act. An expedited DEA…
We remain focused on growing the Company in a smart, profitable manner along with appropriate cost controls.
We continued to pursue many strategies to grow our revenues and expand the scope of our business through the second quarter of 2026 and beyond:
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice